Once-daily long-acting beta₂-agonists/inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease.

ABSTRACT:

SUBMITTER: Sliwka A 

PROVIDER: S-EPMC6513478 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature